間葉系幹細胞の市場規模、シェア、動向分析レポート：製品・サービス別、ワークフロータイプ別、タイプ別、分離源別、適応症別、用途別、地域別、セグメント予測、2024年～2030年

間葉系幹細胞市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の間葉系幹細胞（MSC）市場規模は、2024年から2030年にかけて12.92％のCAGRで拡大し、2030年には72億7,000万米ドルに達すると予測されています。

間葉系幹細胞（MSC）に基づく調査と再生医療分野におけるその意味合いの急激な増加が、業界の拡大に拍車をかけると予測されています。さらに、細胞治療が絶えず進化していることも、間葉系幹細胞市場への投資を促進すると予想されます。大規模な事業会社は、市場での存在感を高めるために、買収という事業戦略で小規模な企業や新興企業をターゲットにしています。

間葉系幹細胞を用いた製品の強力なパイプラインは、間葉系幹細胞の新たな応用と相まって、業界の成長を加速させると予想されます。例えば、米国FDAは2022年に、生命を脅かす様々な疾患に対する約19の幹細胞治療を承認しています。その中には、BMSのBREYANZI、ノバルティスのALLOCORD、KYMIRAHなどが含まれます。さらに、多くの企業が炎症性疾患を管理するための治療体制としてMSCの可能性を模索しており、市場の成長を後押ししています。

例えば、2022年1月、Century Therapeutics社とBristol Myers Squibb社は、IPSC由来の同種細胞療法を拡大するための提携を結びました。さらに、武田薬品/TiGenixの第3相臨床試験では、クローン病における複雑な肛門周囲瘻を対象に間葉系幹細胞が組み込まれました。これは2020年9月時点で最も成功した後期臨床試験です。さらに2022年8月、AGC Biologics社は、ヒト間葉系幹細胞サプライヤーのRoosterBio Inc.と提携し、生命を脅かす疾患に対する臨床的に証明された先進治療を提供します。これらの要因により、主要企業が提供する幹細胞製品の利用が促進され、市場競争が激化すると予測されます。

市場参入企業は、市場ポジションを維持するために、広範な研究開発や他の主要企業との提携・パートナーシップの形成を通じて、提供製品の拡大に注力しています。COVID-19の最近の流行により、複数の研究機関や学術研究機関が間葉系幹細胞を用いた治療法の開発に注力しています。

間葉系幹細胞市場レポートハイライト

• 製品セグメントがこのセグメントを支配し、2023年には78.89%の最大収益シェアを占めました。製品の中でも、細胞および細胞株セグメントは、同セグメントの収益に大きく貢献するものとして浮上しています。
• ワークフロー・タイプに基づくと、培養・凍結保存セグメントが2023年に44.55%の収益シェアを占め、業界を支配しました。このセグメントの成長は、凍結保存サービスに対する高い需要と新興経済諸国におけるヘルスケアインフラの強化に起因しています。
• 2023年の売上高シェアは、同種MSC分野が56.60%と高いです。これは、臨床応用における同種間葉系幹細胞の高い安全性プロファイルに起因します。
• 骨髄セグメントは市場を独占し、2023年には24.56%という最大の売上シェアを占めました。骨髄は間葉系細胞の主要な分離源です。
• 疾患モデル応用分野は、この応用分野で優位を占め、2023年には35.23%の最大収益シェアを占めました。患者特異的MSCを用いた細胞性疾患モデルの使用は、病理学的研究に理想的なツールを提供します。
• 北米が市場を独占し、2023年には45.11%と最大の収益シェアを占めました。同地域の売上高シェアが高いのは、政府の法規制が後押ししていることと、慢性疾患における細胞治療の適用が増加しているためです。

目次

第1章 間葉系幹細胞市場：調査手法と範囲

第2章 間葉系幹細胞市場：エグゼクティブサマリー

• 市場スナップショット
• セグメントスナップショット
• 競合情勢のスナップショット

第3章 間葉系幹細胞市場：変数、動向、範囲

• 市場系統の見通し
• 市場力学
• 業界分析ツール

第4章 製品とサービスのビジネス分析

• 製品およびサービスセグメントダッシュボード
• 間葉系幹細胞市場の製品とサービスの変動分析
• 間葉系幹細胞市場規模と動向分析、製品とサービス別、2018～2030年
• 製品
  • 細胞と細胞株
  • キット、培地、試薬
  • その他
• サービス

第5章 ワークフロービジネス分析

• ワークフローセグメントダッシュボード
• 間葉系幹細胞市場のワークフロー変動分析
• 間葉系幹細胞市場規模と動向分析、ワークフロー別、2018～2030年
• 細胞の調達と分離
• 培養と凍結保存
• 特性評価

第6章 タイプビジネス分析

• タイプセグメントダッシュボード
• 間葉系幹細胞市場タイプ変動分析
• 間葉系幹細胞市場規模と動向分析、タイプ別、2018～2030年
• 自家移植
• 同種異系

第7章 分離の原因ビジネス分析

• 分離セグメントダッシュボードのソース
• 間葉系幹細胞市場の分離変動分析の源
• 間葉系幹細胞市場規模とトレンド分析、分離源別、2018～2030年
• 骨髄
• 臍帯血
• 末梢血
• 卵管
• 胎児肝臓
• 肺
• 脂肪組織

第8章 適応症ビジネス分析

• 適応症セグメントダッシュボード
• 間葉系幹細胞市場の変動分析
• 間葉系幹細胞市場規模と動向分析、適応症別、2018～2030年
• 骨と軟骨の修復
• 循環器疾患
• 炎症性および免疫疾患
• 肝臓疾患
• がん
• 移植片対宿主障害
• その他

第9章 用途ビジネス分析

• 用途セグメントダッシュボード
• 間葉系幹細胞市場の応用変動分析
• 間葉系幹細胞市場規模と動向分析、用途別、2018～2030年
• 疾患モデル
• 医薬品開発と発見
• 幹細胞バンキング
• ヒト組織工学
• 毒性学研究
• その他

第10章 製品とサービス、ワークフローの種類、タイプ、分離元、兆候、用途別の地域ビジネス分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2023年と2030年
• 北米
  • 北米葉系幹細胞市場、2018年-2030年
  • 米国
  • カナダ
• 欧州
  • 欧州間葉系幹細胞市場、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の間葉系幹細胞市場、2018年-2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの間葉系幹細胞市場、2018年-2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ間葉系幹細胞市場、2018-2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • Cell Applications, Inc.
  • Cyagen Biosciences
  • Axol Bioscience Ltd.
  • STEMCELL Technologies
  • Celprogen Inc.
  • Cellcolabs
  • Stemedica Cell Technologies, Inc.
  • Merck KGaA
  • Lonza
  • PromoCell GmbH

List of Tables

• Table 1 List of abbreviations
• Table 2 North America mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
• Table 3 North America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 4 North America mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 5 North America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 6 North America mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 7 North America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 8 North America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 10 U.S. mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 11 U.S. mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 12 U.S. mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 13 U.S. mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 14 U.S. mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 16 Canada mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 17 Canada mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 18 Canada mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 19 Canada mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 20 Canada mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 21 Europe mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
• Table 22 Europe mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 23 Europe mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 24 Europe mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 25 Europe mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 26 Europe mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 27 Europe mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 29 Germany mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 30 Germany mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 31 Germany mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 32 Germany mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 33 Germany mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 34 UK mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 35 UK mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 36 UK mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 37 UK mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 38 UK mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 39 UK mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 40 France mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 41 France mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 42 France mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 43 France mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 44 France mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 45 France mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 46 Italy mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 47 Italy mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 48 Italy mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 49 Italy mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 50 Italy mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 51 Italy mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 52 Spain mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 53 Spain mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 54 Spain mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 55 Spain mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 56 Spain mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 57 Spain mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 58 Denmark mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 59 Denmark mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 60 Denmark mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 61 Denmark mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 62 Denmark mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 63 Denmark mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 64 Sweden mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 65 Sweden mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 66 Sweden mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 67 Sweden mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 68 Sweden mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 69 Sweden mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 70 Norway mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 71 Norway mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 72 Norway mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 73 Norway mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 74 Norway mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 75 Norway mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 82 Asia Pacific mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 83 China mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 84 China mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 85 China mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 86 China mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 87 China mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 88 China mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 89 Japan mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 90 Japan mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 91 Japan mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 92 Japan mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 93 Japan mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 94 Japan mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 95 India mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 96 India mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 97 India mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 98 India mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 99 India mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 100 India mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 101 South Korea mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 102 South Korea mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 103 South Korea mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 104 South Korea mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 105 South Korea mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 106 South Korea mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 107 Australia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 108 Australia mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 109 Australia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 110 Australia mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 111 Australia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 112 Australia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 113 Thailand mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 114 Thailand mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 115 Thailand mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 116 Thailand mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 117 Thailand mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 118 Thailand mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 119 Latin America mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 120 Latin America mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 121 Latin America mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 122 Latin America mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 123 Latin America mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 124 Latin America mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 125 Brazil mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 126 Brazil mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 127 Brazil mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 128 Brazil mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 129 Brazil mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 130 Brazil mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 131 Mexico mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 132 Mexico mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 133 Mexico mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 134 Mexico mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 135 Mexico mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 136 Mexico mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 137 Argentina mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 138 Argentina mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 139 Argentina mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 140 Argentina mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 141 Argentina mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 142 Argentina mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 143 MEA mesenchymal stem cells market, by region, 2018 - 2030 (USD Million)
• Table 144 MEA mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 145 MEA mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 146 MEA mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 147 MEA mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 148 MEA mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 149 MEA mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 150 South Africa mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 151 South Africa mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 152 South Africa mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 153 Saudi Arabia mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 154 Saudi Arabia mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 155 Saudi Arabia mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 156 Saudi Arabia mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 157 Saudi Arabia mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 158 Saudi Arabia mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 159 UAE mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 160 UAE mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 161 UAE mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 162 UAE mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 163 UAE mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 164 UAE mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)
• Table 165 Kuwait mesenchymal stem cells market, by products & services, 2018 - 2030 (USD Million)
• Table 166 Kuwait mesenchymal stem cells market, by workflow type, 2018 - 2030 (USD Million)
• Table 167 Kuwait mesenchymal stem cells market, by type, 2018 - 2030 (USD Million)
• Table 168 Kuwait mesenchymal stem cells market, by source of isolation, 2018 - 2030 (USD Million)
• Table 169 Kuwait mesenchymal stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 170 Kuwait mesenchymal stem cells market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Mesenchymal stem cells market: market outlook
• Fig. 14 Mesenchymal stem cells competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Mesenchymal stem cells market driver impact
• Fig. 20 Mesenchymal stem cells market restraint impact
• Fig. 21 Mesenchymal stem cells market strategic initiatives analysis
• Fig. 22 Mesenchymal stem cells market: Products & services movement analysis
• Fig. 23 Mesenchymal stem cells market: Products & services outlook and key takeaways
• Fig. 24 Products market estimates and forecast, 2018 - 2030
• Fig. 25 Cells & cell lines estimates and forecast, 2018 - 2030.
• Fig. 26 Kits, media, & reagents market estimates and forecast, 2018 - 2030
• Fig. 27 Others market estimates and forecast, 2018 - 2030
• Fig. 28 Services market estimates and forecast, 2018 - 2030
• Fig. 29 Mesenchymal stem cells Market: Workflow type movement Analysis
• Fig. 30 Mesenchymal stem cells market: Workflow type outlook and key takeaways
• Fig. 31 Cell sourcing & isolation market estimates and forecasts, 2018 - 2030
• Fig. 32 Culture & cryopreservation market estimates and forecasts, 2018 - 2030
• Fig. 33 Differentiation market estimates and forecasts, 2018 - 2030
• Fig. 34 Characterization market estimates and forecasts, 2018 - 2030
• Fig. 35 Mesenchymal stem cells Market: Type movement Analysis
• Fig. 36 Mesenchymal stem cells market: Type outlook and key takeaways
• Fig. 37 Autologous market estimates and forecasts, 2018 - 2030
• Fig. 38 Allogenic market estimates and forecasts, 2018 - 2030
• Fig. 39 Mesenchymal stem cells Market: Source of isolation movement Analysis
• Fig. 40 Mesenchymal stem cells market: Source of isolation outlook and key takeaways
• Fig. 41 Bone marrow market estimates and forecasts, 2018 - 2030
• Fig. 42 Cord blood market estimates and forecasts, 2018 - 2030
• Fig. 43 Peripheral blood market estimates and forecasts, 2018 - 2030
• Fig. 44 Fallopian tube market estimates and forecasts, 2018 - 2030
• Fig. 45 Fetal liver market estimates and forecasts, 2018 - 2030
• Fig. 46 Lung market estimates and forecasts, 2018 - 2030
• Fig. 47 Adipose tissues market estimates and forecasts, 2018 - 2030
• Fig. 48 Mesenchymal stem cells Market: Indication movement Analysis
• Fig. 49 Mesenchymal stem cells market: Indication outlook and key takeaways
• Fig. 50 Bone and cartilage repair market estimates and forecasts, 2018 - 2030
• Fig. 51 Cardiovascular diseases market estimates and forecasts, 2018 - 2030
• Fig. 52 Inflammatory and immunological diseases market estimates and forecasts, 2018 - 2030
• Fig. 53 Liver diseases market estimates and forecasts, 2018 - 2030
• Fig. 54 Cancer market estimates and forecasts, 2018 - 2030
• Fig. 55 GvHD market estimates and forecasts, 2018 - 2030
• Fig. 56 Others market estimates and forecasts, 2018 - 2030
• Fig. 57 Mesenchymal stem cells market: application movement analysis
• Fig. 58 Mesenchymal stem cells market: application outlook and key takeaways
• Fig. 59 Disease modeling market estimates and forecasts, 2018 - 2030
• Fig. 60 Drug development & discovery market estimates and forecasts, 2018 - 2030
• Fig. 61 Stem cell banking market estimates and forecasts, 2018 - 2030
• Fig. 62 Tissue engineering market estimates and forecasts, 2018 - 2030
• Fig. 63 Toxicology studies market estimates and forecasts, 2018 - 2030
• Fig. 64 Others market estimates and forecasts, 2018 - 2030
• Fig. 65 Global mesenchymal stem cells market: Regional movement analysis
• Fig. 66 Global mesenchymal stem cells market: Regional outlook and key takeaways
• Fig. 67 North America market estimates and forecasts, 2018 - 2030
• Fig. 68 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 69 Canada market estimates and forecasts, 2018 - 2030
• Fig. 70 Europe market estimates and forecasts, 2018 - 2030
• Fig. 71 UK market estimates and forecasts, 2018 - 2030
• Fig. 72 Germany market estimates and forecasts, 2018 - 2030
• Fig. 73 France market estimates and forecasts, 2018 - 2030
• Fig. 74 Italy market estimates and forecasts, 2018 - 2030
• Fig. 75 Spain market estimates and forecasts, 2018 - 2030
• Fig. 76 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 78 Norway market estimates and forecasts, 2018 - 2030
• Fig. 79 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 80 China market estimates and forecasts, 2018 - 2030
• Fig. 81 Japan market estimates and forecasts, 2018 - 2030
• Fig. 82 India market estimates and forecasts, 2018 - 2030
• Fig. 83 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 84 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 85 Australia market estimates and forecasts, 2018 - 2030
• Fig. 86 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 87 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 89 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 93 UAE market estimates and forecasts, 2018 - 2030
• Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 95 Market share of key market players - Mesenchymal stem cells market

Mesenchymal Stem Cells Market Growth & Trends:

The global mesenchymal stem cells (MSC) market size is expected to reach USD 7.27 billion by 2030, expanding at a CAGR of 12.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S. FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

For instance, on January 2022, the Century Therapeutics and Bristol Myers Squibb entered a collaboration to expand IPSC-derives allogenic cell therapies. In addition, Takeda/TiGenix phase 3 clinical trial incorporated mesenchymal stem cells for complex perianal fistulas in Crohn's Disease. This was the most successful late-stage clinical trial as of September 2020. In addition, in August 2022 AGC Biologics partnered with human mesenchymal stem cell supplier, RoosterBio Inc. to deliver clinically proven advanced therapies for life-threatening conditions. These factors are projected to bolster the usage of stem cell products offered by key entities, thereby intensifying the market competition.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells.

Mesenchymal Stem Cells Market Report Highlights:

• The products segment dominated the segment and accounted for the largest revenue share of 78.89% in 2023. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment's revenue
• Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.55% in 2023. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
• The allogenic MSCs segment accounted for the higher revenue share of 56.60% in 2023. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
• The bone marrow segment dominated the market and accounted for the largest revenue share of 24.56% in 2023. Bone marrow is a major source of isolation for mesenchymal cells
• The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.23% in 2023. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
• North America dominated the market and accounted for the largest revenue share of 45.11% in 2023. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

Table of Contents

Chapter 1. Mesenchymal Stem Cells Market: Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information Or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Mesenchymal Stem Cells Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Mesenchymal Stem Cells Market: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Expanding pipeline and clinical studies of mesenchymal stem cell based products
    • 3.2.1.2. Emerging applications of MSCs
    • 3.2.1.3. Rising market competition among key players
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of standardized & regulated delivery of stem cell therapy
    • 3.2.2.2. Ethical & safety concerns controversies associated with human msc therapy
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Services Business Analysis

• 4.1. Product & Services Segment Dashboard
• 4.2. Mesenchymal Stem Cells Market Product & Services Movement Analysis
• 4.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Cell & Cell Lines
    • 4.4.2.1. Cell & cell lines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Kits, Media, & Reagents
    • 4.4.3.1. Kits, media, & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

• 5.1. Workflow Segment Dashboard
• 5.2. Mesenchymal Stem Cells Market Workflow Movement Analysis
• 5.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 5.4. Cell Sourcing & Isolation
  • 5.4.1. Cell sourcing & isolation market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Culture & Cryopreservation
  • 5.5.1. Culture & cryopreservation market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Differentiation
  • 5.6.1. Differentiation market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Characterization
  • 5.7.1. Characterization market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Type Business Analysis

• 6.1. Type Segment Dashboard
• 6.2. Mesenchymal Stem Cells Market Type Movement Analysis
• 6.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 6.4. Autologous
  • 6.4.1. Autologous market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Allogeneic
  • 6.5.1. Allogeneic market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Source of Isolation Business Analysis

• 7.1. Source of Isolation Segment Dashboard
• 7.2. Mesenchymal Stem Cells Market Source of Isolation Movement Analysis
• 7.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Source of Isolation, 2018 to 2030 (USD Million)
• 7.4. Bone Marrow
  • 7.4.1. Bone marrow market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Cord Blood
  • 7.5.1. Cord blood market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Peripheral Blood
  • 7.6.1. Peripheral blood market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Fallopian Tube
  • 7.7.1. Fallopian tube market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. Fetal Liver
  • 7.8.1. Fetal liver market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.9. Lung
  • 7.9.1. Lung market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.10. Adipose Tissues
  • 7.10.1. Adipose tissues market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Indication Business Analysis

• 8.1. Indication Segment Dashboard
• 8.2. Mesenchymal Stem Cells Market Indication Movement Analysis
• 8.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 8.4. Bone & Cartilage Repair
  • 8.4.1. Bone & cartilage repair market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Cardiovascular Disease
  • 8.5.1. Cardiovascular disease market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Inflammatory & Immunological Diseases
  • 8.6.1. Inflammatory & immunological diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. Liver Diseases
  • 8.7.1. Liver diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.8. Cancer
  • 8.8.1. Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.9. GvHD
  • 8.9.1. GvHD market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.10. Others
  • 8.10.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Application Business Analysis

• 9.1. Application Segment Dashboard
• 9.2. Mesenchymal Stem Cells Market Application Movement Analysis
• 9.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 9.4. Disease Modeling
  • 9.4.1. Disease modeling market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.5. Drug Development & Discovery
  • 9.5.1. Drug development & discovery market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.6. Stem Cell Banking
  • 9.6.1. Stem cell banking market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.7. Tissue Engineering
  • 9.7.1. Tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.8. Toxicology Studies
  • 9.8.1. Toxicology studies market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.9. Others
  • 9.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Regional Business Analysis by Product & Services, Workflow Type, Type, Source of Isolation, Indication, and Application

• 10.1. Regional Dashboard
• 10.2. Market Size & Forecast and Trend Analysis, 2023 & 2030
• 10.3. North America
  • 10.3.1. North America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.3.2. U.S.
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Competitive Scenario
    • 10.3.2.3. Target Disease Prevalence
    • 10.3.2.4. U.S. Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.3.3. Canada
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Competitive Scenario
    • 10.3.3.3. Target Disease Prevalence
    • 10.3.3.4. Canada Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
• 10.4. Europe
  • 10.4.1. Europe Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.2. UK
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Competitive Scenario
    • 10.4.2.3. Target Disease Prevalence
    • 10.4.2.4. UK Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.3. Germany
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Competitive Scenario
    • 10.4.3.3. Target Disease Prevalence
    • 10.4.3.4. Germany Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.4. France
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Competitive Scenario
    • 10.4.4.3. Target Disease Prevalence
    • 10.4.4.4. France Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.5. Italy
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Competitive Scenario
    • 10.4.5.3. Target Disease Prevalence
    • 10.4.5.4. Italy Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.6. Spain
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Competitive Scenario
    • 10.4.6.3. Target Disease Prevalence
    • 10.4.6.4. Spain Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.7. Denmark
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Competitive Scenario
    • 10.4.7.3. Target Disease Prevalence
    • 10.4.7.4. Denmark Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.8. Sweden
    • 10.4.8.1. Key Country Dynamics
    • 10.4.8.2. Competitive Scenario
    • 10.4.8.3. Target Disease Prevalence
    • 10.4.8.4. Sweden Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.4.9. Norway
    • 10.4.9.1. Key Country Dynamics
    • 10.4.9.2. Competitive Scenario
    • 10.4.9.3. Target Disease Prevalence
    • 10.4.9.4. Norway Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Asia Pacific Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.2. Japan
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Competitive Scenario
    • 10.5.2.3. Target Disease Prevalence
    • 10.5.2.4. Japan Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.3. China
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Competitive Scenario
    • 10.5.3.3. Target Disease Prevalence
    • 10.5.3.4. China Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.4. India
    • 10.5.4.1. Key Country Dynamics
    • 10.5.4.2. Competitive Scenario
    • 10.5.4.3. Target Disease Prevalence
    • 10.5.4.4. India Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.5. Australia
    • 10.5.5.1. Key Country Dynamics
    • 10.5.5.2. Competitive Scenario
    • 10.5.5.3. Target Disease Prevalence
    • 10.5.5.4. Australia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.6. Thailand
    • 10.5.6.1. Key Country Dynamics
    • 10.5.6.2. Competitive Scenario
    • 10.5.6.3. Target Disease Prevalence
    • 10.5.6.4. Thailand Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.5.7. South Korea
    • 10.5.7.1. Key Country Dynamics
    • 10.5.7.2. Competitive Scenario
    • 10.5.7.3. Target Disease Prevalence
    • 10.5.7.4. South Korea Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
• 10.6. Latin America
  • 10.6.1. Latin America Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.6.2. Brazil
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Competitive Scenario
    • 10.6.2.3. Target Disease Prevalence
    • 10.6.2.4. Brazil Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.6.3. Mexico
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Competitive Scenario
    • 10.6.3.3. Target Disease Prevalence
    • 10.6.3.4. Mexico Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.6.4. Argentina
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Competitive Scenario
    • 10.6.4.3. Target Disease Prevalence
    • 10.6.4.4. Argentina Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
• 10.7. MEA
  • 10.7.1. MEA Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.7.2. South Africa
    • 10.7.2.1. Key Country Dynamics
    • 10.7.2.2. Competitive Scenario
    • 10.7.2.3. Target Disease Prevalence
    • 10.7.2.4. South Africa Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.7.3. Saudi Arabia
    • 10.7.3.1. Key Country Dynamics
    • 10.7.3.2. Competitive Scenario
    • 10.7.3.3. Target Disease Prevalence
    • 10.7.3.4. Saudi Arabia Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.7.4. UAE
    • 10.7.4.1. Key Country Dynamics
    • 10.7.4.2. Competitive Scenario
    • 10.7.4.3. Target Disease Prevalence
    • 10.7.4.4. UAE Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)
  • 10.7.5. Kuwait
    • 10.7.5.1. Key Country Dynamics
    • 10.7.5.2. Competitive Scenario
    • 10.7.5.3. Target Disease Prevalence
    • 10.7.5.4. Kuwait Mesenchymal Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Company Categorization
• 11.2. Strategy Mapping
• 11.3. Company Market Position Analysis, 2023
• 11.4. Company Profiles/Listing
  • 11.4.1. Thermo Fisher Scientific, Inc.
    • 11.4.1.1. Overview
    • 11.4.1.2. Financial Performance
    • 11.4.1.3. Product Benchmarking
    • 11.4.1.4. Strategic Initiatives
  • 11.4.2. Cell Applications, Inc.
    • 11.4.2.1. Overview
    • 11.4.2.2. Product Benchmarking
    • 11.4.2.3. Strategic Initiatives
  • 11.4.3. Cyagen Biosciences
    • 11.4.3.1. Overview
    • 11.4.3.2. Product Benchmarking
    • 11.4.3.3. Strategic Initiatives
  • 11.4.4. Axol Bioscience Ltd.
    • 11.4.4.1. Overview
    • 11.4.4.2. Product Benchmarking
    • 11.4.4.3. Strategic Initiatives
  • 11.4.5. STEMCELL Technologies
    • 11.4.5.1. Overview
    • 11.4.5.2. Product Benchmarking
    • 11.4.5.3. Strategic Initiatives
  • 11.4.6. Celprogen Inc.
    • 11.4.6.1. Overview
    • 11.4.6.2. Product Benchmarking
    • 11.4.6.3. Strategic Initiatives
  • 11.4.7. Cellcolabs
    • 11.4.7.1. Overview
    • 11.4.7.2. Product Benchmarking
    • 11.4.7.3. Strategic Initiatives
  • 11.4.8. Stemedica Cell Technologies, Inc.
    • 11.4.8.1. Overview
    • 11.4.8.2. Product Benchmarking
    • 11.4.8.3. Strategic Initiatives
  • 11.4.9. Merck KGaA
    • 11.4.9.1. Overview
    • 11.4.9.2. Financial Performance
    • 11.4.9.3. Product Benchmarking
    • 11.4.9.4. Strategic Initiatives
  • 11.4.10. Lonza
    • 11.4.10.1. Overview
    • 11.4.10.2. Financial Performance
    • 11.4.10.3. Product Benchmarking
    • 11.4.10.4. Strategic Initiatives
  • 11.4.11. PromoCell GmbH
    • 11.4.11.1. Overview
    • 11.4.11.2. Product Benchmarking
    • 11.4.11.3. Strategic Initiatives